A preliminary report on the "SNBTS Evaluation of the Ortho HCV Antibody ELISA Test System" looked at transfusion recipients, and found that 1 in 33 multi-transfused patients screened positive (3%). 92 of 146 people with haemophilia from the West of Scotland whose samples were tested were shown to be repeatedly reactive for anti-HCV (63%).